Document Detail


Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g.
MedLine Citation:
PMID:  8164699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The administration of surfactant decreased mortality, morbidity, and costs of care for very-low-birth-weight infants in clinical trials. The extent to which these benefits can be achieved in the usual clinical settings is not known. METHODS: We analyzed clinical and financial data obtained from 1985 to 1990 at 14 perinatal centers in the United States on 5629 neonates weighing 500 to 1500 g. The infants were divided into groups according to whether they were born before or after surfactant was introduced into clinical practice. Regression models controlling for race, sex, and birth weight were used to assess mortality, morbidity, and use of resources. Mortality rates specific for these variables were projected to the nation as a whole with reference to the 1985 U.S. birth cohort. RESULTS: The odds of death in the hospital for very-low-birth-weight infants were reduced by 30 percent after surfactant was introduced. Among infants with bronchopulmonary dysplasia, mortality declined 40 percent. Projections of mortality nationwide declined 5 percent. Eighty percent of the decline in the U.S. infant mortality rate between 1989 and 1990 could be attributed solely to the use of surfactant. Among the survivors, the overall odds of morbidity did not change, whether or not we adjusted for changes in race, sex, and birth weight. The odds of respiratory distress syndrome and pulmonary interstitial emphysema among the survivors declined by 20 percent and 40 percent, respectively, with surfactant. Inflation-adjusted charges per survivor declined by 10 percent, or $5,800, whereas the cost of care for each infant who died declined by 31 percent, or $4,400. CONCLUSIONS: The introduction of surfactant has led to decreased mortality and morbidity in very-low-birth-weight infants and to decreased use of resources both for infants who survive and for those who die.
Authors:
R M Schwartz; A M Luby; J W Scanlon; R J Kellogg
Related Documents :
94509 - Fanconi's anemia: the preanemic phase.
19119339 - Recurrence and outcome in skull base meningiomas: do they differ from other intracrania...
17302519 - Outcome of infants born at 21-28 weeks' gestation in an inner-city hospital over an eig...
18723909 - Single versus multiple courses of antenatal betamethasone and neonatal outcome: a rando...
21772139 - Early life exposures: impact on asthma and allergic disease.
21829409 - Respiratory syncytial virus infection in children with congenital heart disease: global...
16890219 - General and specific mortality among the elderly during the 2003 heat wave in genoa (it...
7586919 - Congenital diaphragmatic hernia. outcome of preoperative extracorporeal membrane oxygen...
25323589 - Safety of therapeutics used in management of patent ductus arteriosus in preterm infants.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The New England journal of medicine     Volume:  330     ISSN:  0028-4793     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-05-26     Completed Date:  1994-05-26     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1476-80     Citation Subset:  AIM; IM    
Affiliation:
National Perinatal Information Center, Providence, RI 02908.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Health Resources / economics,  utilization*
Humans
Infant, Low Birth Weight*
Infant, Newborn
Infant, Newborn, Diseases / economics,  epidemiology,  mortality,  prevention & control*
Male
Morbidity
Pulmonary Surfactants / therapeutic use*
Retrospective Studies
United States / epidemiology
Grant Support
ID/Acronym/Agency:
N01-H0-29024//PHS HHS
Chemical
Reg. No./Substance:
0/Pulmonary Surfactants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuropathological findings in the brain of Karen Ann Quinlan. The role of the thalamus in the persis...
Next Document:  Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Ele...